DT
CCXI

Diversified Trust’s ChemoCentryx, Inc. CCXI Stock Holding History

Diversified Trust’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-7,772
Closed -$447K – 704
2020
Q2 		$447K Buy
+7,772
New +$423K 0.02% 279

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Diversified Trust's CCXI Position: Q3 2020 in Review

Diversified Trust sold out of ChemoCentryx, Inc. (CCXI) in Q3 2020, closing a stake of 7,772 shares — an estimated $447K sold.

Diversified Trust first reported a position in CCXI in Q2 2020 and held it in 1 quarter. The position peaked at $447K in Q2 2020. 204 funds tracked by Wall St. Rank hold CCXI as of Q3 2020.

  • Diversified Trust reported no remaining ChemoCentryx, Inc. position as of Q3 2020 after selling out during the quarter.
  • Diversified Trust sold 7,772 ChemoCentryx, Inc. shares in Q3 2020, an estimated $447K.
  • Diversified Trust first reported a position in ChemoCentryx, Inc. in Q2 2020 and held it in 1 quarter.
  • Diversified Trust's ChemoCentryx, Inc. position peaked at $447K in Q2 2020.
  • 204 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2020.

Based on Diversified Trust's 13F filing for Q3 2020, filed 15 Oct 2020.